Thousands tracked to see how a Drug-Coated stent performs in daily use
NCT ID NCT05505929
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This registry is following 10,000 people who receive the BioFreedom Ultra stent, a device coated with the drug biolimus A9 to keep heart arteries open. The goal is to see how well the stent works in real-world patients, not just in controlled trials. Researchers will track problems like the need for repeat procedures, heart attacks, or stent blockages over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Biolimus A9-coated coronary stent
- What this could lead to
- If successful, this registry will confirm that the BioFreedom Ultra stent works safely in everyday patients, supporting its continued use for coronary artery disease.
- What could go wrong
- This is an observational registry, not a controlled trial, so results may be influenced by patient differences. It does not test a new treatment, only monitors existing practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Al Qassimi Hospital
RECRUITINGSharjah city, United Arab Emirates
-
Clinique Des Domes Psr
RECRUITINGClermont-Ferrand, France
-
Golden Jubilee National Hospital
RECRUITINGGlasgow, United Kingdom
-
Hospital Marques Valdecilla
RECRUITINGSantander, Spain
-
Klinikum Lippe
RECRUITINGDetmold, Germany
-
Krankenhaus Barmherzige Brüder
RECRUITINGEisenstadt, Austria
-
Military hospital
RECRUITINGTunis, Tunisia
-
Royal Bournemouth hospital
RECRUITINGBournemouth, United Kingdom
-
University and Hospital Fribourg
RECRUITINGFribourg, Switzerland
-
Universitäres Herzzentrum
RECRUITINGZurich, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?